NEWARK, California–(BUSINESS WIRE)–Oraya Therapeutics ha annunciato in data odierna che la Società di oftalmologia tedesca, la Società per la retina e l’Associazione professionale degli oftalmologi tedeschi hanno rilasciato un parere congiunto sull’uso coadiuvante della radioterapia insieme al sistema di radioterapia stereotassica IRay® per il trattamento della degenerazione maculare neovascolare legata all’età. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la
LARGO, Fla.–(BUSINESS WIRE)–Ken Beckman, MD, President of CEDARS/ASPENS has stated, “We would like to extend our sincere thanks to Allergan, Bausch + Lomb, Shire, and Omeros for their annual support of CEDARS/ASPENS and for their enthusiasm and foresight in supporting the Society. These Annual Sponsorships as well as our Conference Sponsorships allow us to continue our work in shaping the future of anterior segment care through Innovation, Collaboration, and Education (I·C·E.) We look forward
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its 2015 third quarter results on…
LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek Pharmaceuticals Initiates Dosing of MATRx- 1, the First Pivotal Phase 3 Clinical Trial of Trabodenoson, a Novel Treatment for Glaucoma
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven Biotherapeutics completed patient enrollment in its first pivotal, Phase 3 clinical study of isunakinra (EBI-005) in patients with moderate to severe allergic conjunctivitis.
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced the enrollment of the first patients in a third Phase 3 clinical trial for DEXTENZATM (sustained release dexamethasone) 0.4mg Intracanalicular Depot, for the treatment of post-surgical ocular inflammation and pain. Based on the results of the Company’s two previously c
ARLINGTON, Va.–(BUSINESS WIRE)–The CEA Foundation is pleased to announce the winners of its first “technology that improves lives” video contest. Aipoly, HelpAround, Los Angeles Low Vision, Perceptive Devices and WHILL were selected from more than 20…
ELK GROVE VILLAGE, Ill.–(BUSINESS WIRE)–VSP Optics Group deploys an automated material handling solution from Wynright and Daifuku N.A. to marry the right frames and lenses so people get their prescription eye glasses faster.
LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek Pharmaceuticals Appoints Gary M. Phillips, MD, MBA, to Board of Directors
STOCKHOLM–(BUSINESS WIRE)–Regulatory News: Tobii AB (STO:TOBII) plans to publish the interim report for the period January 1—September 30 on November 3 at 08.00 CET. Following this report Tobii will arrange a conference call with web cast presentation for investors, analysts and media. Tobii’s President and CEO Henrik Eskilsson and CFO Esben Olesen will present and comment on the report. After the presentation there will be time for questions. The presentation will be held in English. Time Tu
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, which develops drug therapies for eye diseases, announces completion of Phase 2 clinical trial enrollment for treatment of macular edema associated with non-infectious uveitis.
CINCINNATI–(BUSINESS WIRE)–Aerpio Therapeutics, Inc., a biopharmaceutical company focused on advancing first-in-class treatments for the eye, today announced that data from the TIME-2 Phase 2a Study of AKB-9778 in the treatment of patients with diabetic macular edema (DME) will be presented at the upcoming American Academy of Ophthalmology (AAO) Annual Meeting’s Retina Subspecialty Day. In July, the company announced data showing that a combination of AKB-9778 and Lucentis® provided significa
NEW YORK–(BUSINESS WIRE)–National law firm Robins Kaplan LLP announced today that it has been named co-lead counsel in antitrust litigation against the four dominant manufacturers and the largest nationwide distributor of contact lenses. As co-lead counsel, Robins Kaplan represents a proposed class of individual consumers that purchased contact lenses from retailers and eye care professionals that could number in the millions. Robins Kaplan filed one of the first class action complaints on be
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche group (SIX: RO, ROG; OTCQX: RHHBY) today announced data from three positive, pivotal Phase III studies of ocrelizumab in people with relapsing multiple sclerosis (MS) and pr…
NEW ORLEANS & WASHINGTON–(BUSINESS WIRE)–RightEye LLC, a health technology company using eye tracking to revolutionize vision performance and patient care, today announced at the 2015 American Academy of Optometry show in New Orleans the launch of RightEye Neuro Vision — a new 15-second concussion test that helps health care providers more clearly understand the severity of a patient’s head trauma and better assess their recovery over time. “It’s common for concussion patients to be in denial
CINCINNATI–(BUSINESS WIRE)–OneSight, an independent nonprofit committed to eradicating the global vision care crisis, today announced the findings from The Global Need for Glasses Study, conducted in collaboration with Deloitte
BENTONVILLE, Ark.–(BUSINESS WIRE)–Building on its commitment to making healthcare and healthier food more affordable and accessible, Walmart today outlined additional ways the company is helping its customers live healthier lives. The retailer will focus on preventive care and supporting overall well-being across its entire assortment – in stores and online – through in-store events, online education and an expanded assortment of products and services solutions. Customers will see Walmart’s c
LONDON–(BUSINESS WIRE)–Technavio has published a new report on the global energy-based therapeutics market, which is expected to grow at a CAGR of more than 7% from 2015-2019.